300966 共同药业
已收盘 11-06 15:00:00
资讯
新帖
简况
中银证券：给予共同药业买入评级
证券之星 · 10-30
中银证券：给予共同药业买入评级
共同药业（300966）2026年三季报简析：增收不增利
证券之星 · 10-28
共同药业（300966）2026年三季报简析：增收不增利
共同药业（300966）10月27日主力资金净买入283.02万元
证券之星 · 10-28
共同药业（300966）10月27日主力资金净买入283.02万元
股市必读：共同药业新发布《2026年三季度报告》
证券之星 · 10-28
股市必读：共同药业新发布《2026年三季度报告》
图解共同药业三季报：第三季度单季净利润同比增长25.15%
证券之星 · 10-26
图解共同药业三季报：第三季度单季净利润同比增长25.15%
共同药业(300966.SZ)发布前三季度业绩，归母净亏损4877.1万元
智通财经 · 10-26
共同药业(300966.SZ)发布前三季度业绩，归母净亏损4877.1万元
共同药业（300966）10月22日主力资金净买入1145.08万元
证券之星 · 10-23
共同药业（300966）10月22日主力资金净买入1145.08万元
股市必读：共同药业新发布《第三届董事会第十六次会议决议公告》
证券之星 · 10-13
股市必读：共同药业新发布《第三届董事会第十六次会议决议公告》
共同药业（300966）披露拟开展外汇衍生品交易业务公告，10月12日股价下跌0.57%
证券之星 · 10-12
共同药业（300966）披露拟开展外汇衍生品交易业务公告，10月12日股价下跌0.57%
共同药业（300966）10月8日主力资金净卖出296.68万元
证券之星 · 10-09
共同药业（300966）10月8日主力资金净卖出296.68万元
股市必读：共同药业新发布《关于2026年第三季度可转换公司债券转股情况的公告》
证券之星 · 10-09
股市必读：共同药业新发布《关于2026年第三季度可转换公司债券转股情况的公告》
共同药业（300966）9月30日主力资金净买入422.28万元
证券之星 · 10-08
共同药业（300966）9月30日主力资金净买入422.28万元
共同药业（300966）9月24日主力资金净卖出169.48万元
证券之星 · 09-28
共同药业（300966）9月24日主力资金净卖出169.48万元
共同药业（300966）9月23日主力资金净卖出8.05万元
证券之星 · 09-24
共同药业（300966）9月23日主力资金净卖出8.05万元
股市必读：共同药业新发布《关于持股5%以上股东、董事减持计划期限届满暨减持结果的公告》
证券之星 · 09-14
股市必读：共同药业新发布《关于持股5%以上股东、董事减持计划期限届满暨减持结果的公告》
中银证券：给予共同药业买入评级
证券之星 · 08-31
中银证券：给予共同药业买入评级
共同药业（300966）2026年中报简析：增收不增利，短期债务压力上升
证券之星 · 08-27
共同药业（300966）2026年中报简析：增收不增利，短期债务压力上升
股市必读：共同药业新发布《2026年半年度报告摘要》
证券之星 · 08-27
股市必读：共同药业新发布《2026年半年度报告摘要》
共同药业(300966.SZ)发布上半年业绩，归母净亏损3284.13万元
智通财经 · 08-25
共同药业(300966.SZ)发布上半年业绩，归母净亏损3284.13万元
图解共同药业中报：第二季度单季净利润同比下降194.57%
证券之星 · 08-25
图解共同药业中报：第二季度单季净利润同比下降194.57%
加载更多
公司概况
公司名称：
湖北共同药业集团股份有限公司
所属行业：
医药制造业
上市日期：
2021-04-09
主营业务：
湖北共同药业集团股份有限公司的主营业务是甾体药物原料的研发、生产及销售。公司的主要产品是雄烯二酮（AD）、雄二烯二酮（ADD）、双降醇（BA）、9-羟基雄烯二酮（9OH-AD）。
发行价格：
8.24
{"stockData":{"symbol":"300966","market":"SZ","secType":"STK","nameCN":"共同药业","latestPrice":24.72,"timestamp":1793948616000,"preClose":24.85,"halted":0,"volume":2556250,"delay":0,"changeRate":-0.0052,"floatShares":76580100,"shares":114999999,"eps":-0.7781,"marketStatus":"已收盘","change":-0.13,"latestTime":"11-06 15:00:00","open":24.04,"high":25,"low":23.69,"amount":62573900,"amplitude":0.0527,"askPrice":24.74,"askSize":7,"bidPrice":24.72,"bidSize":585,"shortable":0,"etf":0,"ttmEps":-0.7781,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794187800000},"marketStatusCode":5,"adr":0,"adjPreClose":24.85,"symbolType":"stock","openAndCloseTimeList":[[1793928600000,1793935800000],[1793941200000,1793948400000]],"highLimit":27.34,"lowLimit":22.37,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":115281113,"isCdr":false,"pbRate":4.22,"roa":"--","roe":"--","epsLYR":-0.64,"committee":0.458034,"marketValue":2850000000,"turnoverRate":0.0334,"status":1,"floatMarketCap":1893000000},"requestUrl":"/m/hq/s/300966","defaultTab":"news","newsList":[{"id":"2679651132","title":"中银证券：给予共同药业买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2679651132","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679651132?lang=zh_cn&edition=full","pubTime":"2026-10-30 13:45","pubTimestamp":1793339137,"startTime":"0","endTime":"0","summary":"中银国际证券股份有限公司刘恩阳,苏雪儿近期对共同药业进行研究并发布了研究报告《营收延续增长，Q3毛利率环比修复》，给予共同药业买入评级。公司核心甾体系列产品稳步增长，高端原料药海外审批有序推进，公司业绩有望实现稳健增长，维持买入评级。最新盈利预测明细如下：该股最近90天内共有1家机构给出评级，买入评级1家。本文数据来源于中银国际证券股份有限公司，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000030082.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300966","601696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678498100","title":"共同药业（300966）2026年三季报简析：增收不增利","url":"https://stock-news.laohu8.com/highlight/detail?id=2678498100","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678498100?lang=zh_cn&edition=full","pubTime":"2026-10-28 20:40","pubTimestamp":1793191244,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期共同药业发布2026年三季报。根据财报显示，共同药业增收不增利。其中，毛利率14.75%，同比减20.23%，净利率-10.82%，同比减31.57%，销售费用、管理费用、财务费用总计9816.07万元，三费占营收比19.08%，同比增5.94%，每股净资产5.89元，同比减12.35%，每股经营性现金流0.4元，同比增852.68%，每股收益-0.42元，同比减50.0%证券之星价投圈财报分析工具显示：业务评价：去年的净利率为-13.48%，算上全部成本后，公司产品或服务的附加值不高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800047987.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678438058","title":"共同药业（300966）10月27日主力资金净买入283.02万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2678438058","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678438058?lang=zh_cn&edition=full","pubTime":"2026-10-28 09:20","pubTimestamp":1793150455,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月27日收盘，共同药业报收于23.01元，下跌5.97%，换手率3.22%，成交量2.47万手，成交额5862.22万元。10月27日的资金流向数据方面，主力资金净流入283.02万元，占总成交额4.83%，游资资金净流入171.97万元，占总成交额2.93%，散户资金净流出454.99万元，占总成交额7.76%。近5日资金流向一览见下表：共同药业融资融券信息显示，融资方面，当日融资买入260.14万元，融资偿还397.96万元，融资净偿还137.82万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800015403.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678485566","title":"股市必读：共同药业新发布《2026年三季度报告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2678485566","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678485566?lang=zh_cn&edition=full","pubTime":"2026-10-28 04:13","pubTimestamp":1793132026,"startTime":"0","endTime":"0","summary":"截至2026年10月27日收盘，共同药业报收于23.01元，下跌5.97%，换手率3.22%，成交量2.47万手，成交额5862.22万元。公司公告汇总：2026年三季度公司实现营业收入168,329,930.14元，同比增长10.26%；归母净利润为-15,929,645.67元，同比减少25.15%。年初至报告期末营业收入为514,602,951.36元，同比增长13.08%；归属于上市公司股东的净利润为-48,770,960.98元，同比减少50.37%。经营活动产生的现金流量净额为46,410,439.99元，同比增长852.68%。总资产为2,954,908,478.23元，较上年度末增长3.66%；归属于上市公司股东的所有者权益为775,711,213.45元，较上年度末下降6.11%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800005715.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300966","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678698141","title":"图解共同药业三季报：第三季度单季净利润同比增长25.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678698141","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678698141?lang=zh_cn&edition=full","pubTime":"2026-10-26 17:38","pubTimestamp":1793007525,"startTime":"0","endTime":"0","summary":"证券之星消息，共同药业2026年三季报显示，前三季度公司主营收入5.15亿元，同比上升13.08%；归母净利润-4877.1万元，同比下降50.37%；扣非净利润-4825.96万元，同比下降49.81%；其中2026年第三季度，公司单季度主营收入1.68亿元，同比上升10.26%；单季度归母净利润-1592.96万元，同比上升25.15%；单季度扣非净利润-1559.42万元，同比上升29.1%；负债率71.16%，投资收益-620.13万元，财务费用4405.07万元，毛利率14.75%。财报数据概要请见下图:本文数据来源于共同药业2026年三季报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600023602.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678621150","title":"共同药业(300966.SZ)发布前三季度业绩，归母净亏损4877.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2678621150","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678621150?lang=zh_cn&edition=full","pubTime":"2026-10-26 15:57","pubTimestamp":1793001452,"startTime":"0","endTime":"0","summary":"智通财经APP讯，共同药业(300966.SZ)发布2026年三季度报告，前三季度，公司实现营业收入5.15亿元，同比增长13.08%。归属于上市公司股东净亏损4877.1万元。归属于上市公司股东的扣除非经常性损益净亏损4825.96万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1512323.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","300966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677691512","title":"共同药业（300966）10月22日主力资金净买入1145.08万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677691512","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677691512?lang=zh_cn&edition=full","pubTime":"2026-10-23 09:14","pubTimestamp":1792718091,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月22日收盘，共同药业报收于23.08元，下跌7.42%，换手率6.23%，成交量4.77万手，成交额1.11亿元。10月22日的资金流向数据方面，主力资金净流入1145.08万元，占总成交额10.3%，游资资金净流入856.05万元，占总成交额7.7%，散户资金净流出2001.12万元，占总成交额18.0%。近5日资金流向一览见下表：共同药业融资融券信息显示，融资方面，当日融资买入645.74万元，融资偿还407.35万元，融资净买入238.39万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300009388.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300966","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675807532","title":"股市必读：共同药业新发布《第三届董事会第十六次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2675807532","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675807532?lang=zh_cn&edition=full","pubTime":"2026-10-13 03:25","pubTimestamp":1791833109,"startTime":"0","endTime":"0","summary":"关于开展外汇衍生品交易业务的公告湖北共同药业集团股份有限公司拟在12个月内开展总额不超过30,000万元人民币的外汇衍生品交易业务，预计动用保证金和权利金不超过1,000万元，资金来源为自有资金；交易品种包括外汇远期合约结售汇、人民币对外汇期权，交易对手为具备资质的金融机构；该事项已经公司第三届董事会第十六次会议审议通过，无需提交股东大会审议；公司强调不进行投机交易，遵循套期保值原则，并已制定相应风险控制措施。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101300003798.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300966","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674952806","title":"共同药业（300966）披露拟开展外汇衍生品交易业务公告，10月12日股价下跌0.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674952806","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674952806?lang=zh_cn&edition=full","pubTime":"2026-10-12 23:04","pubTimestamp":1791817464,"startTime":"0","endTime":"0","summary":"截至2026年10月12日收盘，共同药业报收于24.61元，较前一交易日下跌0.57%，最新总市值为28.37亿元。该股当日开盘24.96元，最高25.2元，最低24.1元，成交额达3651.32万元，换手率为1.94%。公告显示，湖北共同药业集团股份有限公司为防范外汇风险，拟在12个月内开展总额不超过30,000万元人民币的外汇衍生品交易业务，预计动用保证金和权利金不超过1,000万元，资金来源为自有资金。交易品种包括外汇远期合约结售汇、人民币对外汇期权，交易对手为具备资质的金融机构。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200036222.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674712881","title":"共同药业（300966）10月8日主力资金净卖出296.68万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674712881","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674712881?lang=zh_cn&edition=full","pubTime":"2026-10-09 09:21","pubTimestamp":1791508862,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月8日收盘，共同药业报收于24.62元，下跌4.2%，换手率2.81%，成交量2.15万手，成交额5356.86万元。10月8日的资金流向数据方面，主力资金净流出296.68万元，占总成交额5.54%，游资资金净流入220.14万元，占总成交额4.11%，散户资金净流入76.53万元，占总成交额1.43%。近5日资金流向一览见下表：共同药业融资融券信息显示，融资方面，当日融资买入390.25万元，融资偿还258.06万元，融资净买入132.2万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900007386.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300966","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674100232","title":"股市必读：共同药业新发布《关于2026年第三季度可转换公司债券转股情况的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2674100232","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674100232?lang=zh_cn&edition=full","pubTime":"2026-10-09 02:34","pubTimestamp":1791484449,"startTime":"0","endTime":"0","summary":"截至2026年10月8日收盘，共同药业报收于24.62元，下跌4.2%，换手率2.81%，成交量2.15万手，成交额5356.86万元。当日关注点交易信息汇总：10月8日主力资金净流出296.68万元，占总成交额5.54%。公司公告汇总：“共同转债”2026年第三季度无新增转股，截至9月30日剩余可转债3,798,878张，票面总金额379,887,800元；公司总股本维持115,281,113股不变。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900002380.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300966","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673049712","title":"共同药业（300966）9月30日主力资金净买入422.28万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2673049712","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673049712?lang=zh_cn&edition=full","pubTime":"2026-10-08 09:08","pubTimestamp":1791421681,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月30日收盘，共同药业报收于25.7元，上涨2.72%，换手率2.89%，成交量2.22万手，成交额5678.2万元。9月30日的资金流向数据方面，主力资金净流入422.28万元，占总成交额7.44%，游资资金净流出50.19万元，占总成交额0.88%，散户资金净流出372.09万元，占总成交额6.55%。近5日资金流向一览见下表：共同药业融资融券信息显示，融资方面，当日融资买入161.93万元，融资偿还242.64万元，融资净偿还80.71万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800003014.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670407741","title":"共同药业（300966）9月24日主力资金净卖出169.48万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2670407741","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670407741?lang=zh_cn&edition=full","pubTime":"2026-09-28 09:24","pubTimestamp":1790558663,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月24日收盘，共同药业报收于25.48元，下跌4.21%，换手率2.9%，成交量2.22万手，成交额5770.02万元。9月24日的资金流向数据方面，主力资金净流出169.48万元，占总成交额2.94%，游资资金净流入256.18万元，占总成交额4.44%，散户资金净流出86.7万元，占总成交额1.5%。近5日资金流向一览见下表：共同药业融资融券信息显示，融资方面，当日融资买入411.37万元，融资偿还501.25万元，融资净偿还89.88万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800002937.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300966","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669301854","title":"共同药业（300966）9月23日主力资金净卖出8.05万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2669301854","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669301854?lang=zh_cn&edition=full","pubTime":"2026-09-24 09:09","pubTimestamp":1790212199,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月23日收盘，共同药业报收于26.6元，上涨2.62%，换手率3.82%，成交量2.93万手，成交额7658.98万元。9月23日的资金流向数据方面，主力资金净流出8.05万元，占总成交额0.11%，游资资金净流出17.84万元，占总成交额0.23%，散户资金净流入25.89万元，占总成交额0.34%。近5日资金流向一览见下表：共同药业融资融券信息显示，融资方面，当日融资买入517.06万元，融资偿还727.12万元，融资净偿还210.06万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400009015.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300966","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667287638","title":"股市必读：共同药业新发布《关于持股5%以上股东、董事减持计划期限届满暨减持结果的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2667287638","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667287638?lang=zh_cn&edition=full","pubTime":"2026-09-14 03:56","pubTimestamp":1789329373,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，共同药业报收于23.0元，上涨0.35%，换手率2.65%，成交量2.04万手，成交额4634.53万元。公司公告汇总：持股5%以上股东、董事李明磊减持计划期限届满，通过大宗交易减持2,197,222股，减持后持股比例为10.0000%。交易信息汇总资金流向9月11日主力资金净流出145.5万元，占总成交额3.14%；游资资金净流入474.21万元，占总成交额10.23%；散户资金净流出328.72万元，占总成交额7.09%。减持后李明磊合计持有股份11,528,078股，占总股本10.0000%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400001698.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663191074","title":"中银证券：给予共同药业买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2663191074","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663191074?lang=zh_cn&edition=full","pubTime":"2026-08-31 18:19","pubTimestamp":1788171568,"startTime":"0","endTime":"0","summary":"中银国际证券股份有限公司刘恩阳,苏雪儿近期对共同药业进行研究并发布了研究报告《营收保持增长，静待产能爬坡与盈利修复》，给予共同药业买入评级。随着公司新布局高端原料药业务逐步落地，产能利用率提升，海外业务拓展持续深化，公司收入有望保持稳定增长，维持买入评级。最新盈利预测明细如下：该股最近90天内共有1家机构给出评级，买入评级1家。本文数据来源于中银国际证券股份有限公司，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100026518.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300966","601696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662728143","title":"共同药业（300966）2026年中报简析：增收不增利，短期债务压力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2662728143","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662728143?lang=zh_cn&edition=full","pubTime":"2026-08-27 06:48","pubTimestamp":1787784517,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期共同药业发布2026年中报。截至本报告期末，公司营业总收入3.46亿元，同比上升14.51%，归母净利润-3284.13万元，同比下降194.47%。本报告期共同药业短期债务压力上升，流动比率达0.93。本次财报公布的各项数据指标表现一般。融资分红：公司上市5年以来，累计融资总额2.39亿元，累计分红总额2270.98万元，分红融资比为0.1。本文数据来源于共同药业2026年中报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700013485.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662744104","title":"股市必读：共同药业新发布《2026年半年度报告摘要》","url":"https://stock-news.laohu8.com/highlight/detail?id=2662744104","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662744104?lang=zh_cn&edition=full","pubTime":"2026-08-27 04:22","pubTimestamp":1787775731,"startTime":"0","endTime":"0","summary":"截至2026年8月26日收盘，共同药业报收于24.32元，下跌1.98%，换手率5.95%，成交量4.56万手，成交额1.1亿元。公司公告汇总：2026年半年度报告摘要显示，营业收入同比增长14.51%，但归母净利润为-3284.13万元，同比减少194.47%；经营活动现金流量净额同比增长487.99%。公司公告汇总：截至2026年上半年末，非经营性资金占用期末余额合计为34,546.92万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700009735.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300966","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662731952","title":"共同药业(300966.SZ)发布上半年业绩，归母净亏损3284.13万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2662731952","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662731952?lang=zh_cn&edition=full","pubTime":"2026-08-25 19:42","pubTimestamp":1787658172,"startTime":"0","endTime":"0","summary":"智通财经APP讯，共同药业(300966.SZ)发布2026年半年度报告，报告期内，公司实现营业收入3.46亿元，同比增长14.51%。归属于上市公司股东净亏损3284.13万元，归属于上市公司股东的扣除非经常性损益净亏损3266.54万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1485290.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300966","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662356807","title":"图解共同药业中报：第二季度单季净利润同比下降194.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662356807","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662356807?lang=zh_cn&edition=full","pubTime":"2026-08-25 18:24","pubTimestamp":1787653473,"startTime":"0","endTime":"0","summary":"证券之星消息，共同药业2026年中报显示，上半年度公司主营收入3.46亿元，同比上升14.51%；归母净利润-3284.13万元，同比下降194.47%；扣非净利润-3266.54万元，同比下降219.65%；其中2026年第二季度，公司单季度主营收入1.84亿元，同比上升12.96%；单季度归母净利润-3603.98万元，同比下降194.57%；单季度扣非净利润-3595.65万元，同比下降211.16%；负债率69.96%，投资收益-409.58万元，财务费用2855.92万元，毛利率14.08%。财报数据概要请见下图:本文数据来源于共同药业2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500039144.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300966"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1794019191098,"stockEarnings":[{"period":"1week","weight":0.0317},{"period":"1month","weight":-0.0381},{"period":"3month","weight":-0.0793},{"period":"6month","weight":-0.1158},{"period":"1year","weight":0.1082},{"period":"ytd","weight":0.2573}],"compareEarnings":[{"period":"1week","weight":0.0139},{"period":"1month","weight":-0.0502},{"period":"3month","weight":-0.0738},{"period":"6month","weight":-0.127},{"period":"1year","weight":-0.0895},{"period":"ytd","weight":-0.0805}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"湖北共同药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"10191人(较上一季度减少11.12%)","perCapita":"7514股","listingDate":"2021-04-09","address":"湖北省襄阳市宜城市小河镇高坑一组","registeredCapital":"11528万元","survey":" 湖北共同药业集团股份有限公司的主营业务是甾体药物原料的研发、生产及销售。公司的主要产品是雄烯二酮（AD）、雄二烯二酮（ADD）、双降醇（BA）、9-羟基雄烯二酮（9OH-AD）。","listedPrice":8.24},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"共同药业(300966)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供共同药业(300966)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"共同药业,300966,共同药业股票,共同药业股票老虎,共同药业股票老虎国际,共同药业行情,共同药业股票行情,共同药业股价,共同药业股市,共同药业股票价格,共同药业股票交易,共同药业股票购买,共同药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"共同药业(300966)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供共同药业(300966)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}